Curavisc

by Bioventus (USA)

Originally, Curavisc® was developed and manufactured by Curasan AG, a German company specializing in biomaterials for bone and tissue regeneration. However, in 2021, Bioventus acquired the rights to Curavisc® and other viscosupplementation products from Curasan AG.

Bioventus LLC is a U.S.-based global company that develops, manufactures, and markets medical products focused on orthobiologics, joint preservation, and osteoarthritis pain relief. Their portfolio includes devices and therapies for bone healing, osteoarthritis management, and other orthopedic conditions.

Curavisc (1×2 ml)

Curavisc (1×2 ml)

Syringe 1 x 2mL
Sodium Hyaluronate 20mg/2mL

Curavisc® is a pre-filled syringe containing 2 ml of sterile 1% Sodium Hyaluronate solution, designed for viscosupplementation to relieve joint pain and improve mobility in traumatic or degenerative joint conditions. The product is packaged in a sterile blister pack within a protective cardboard box, which includes usage instructions and a traceability label.

IS YOUR PRODUCT MISSING FROM OUR RANGE?

Get in touch to hear more about how to become a supplier.

CONTACT US